Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Foresite Capital Management
Biotech
Eikon remains in megaround mode with $350M series D
Eikon is no stranger to megarounds, and the cancer-focused biotech has continued this trend with $350 million to fuel its clinical trials.
James Waldron
Feb 26, 2025 9:40am
Foresite raises $900M to make fresh set of big biotech bets
Jun 12, 2024 9:00am
Alumis raises $259M in 2024's largest biotech round so far
Mar 6, 2024 8:00am
Troubled Theseus mulls bids from both OrbiMed and Concentra
Nov 27, 2023 9:31am
Kinnate buys OrbiMed's stake in cancer JV to go solo in China
Feb 22, 2023 9:30am
Foresite Labs nabs $173M fund for data-fueled biotechs
Mar 3, 2022 12:00pm
